Pharmaceutical Technology
NOVEMBER 21, 2023
Texas AG has sued Pfizer and Tris Pharma for providing adulterated attention-deficit/hyperactivity disorder drug, Quillivant XR, to children.
Bio Pharma Dive
NOVEMBER 21, 2023
The partnership is another investment by the biotech subsidiary in artificial intelligence for drug discovery and development, continuing an industry trend.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
NOVEMBER 21, 2023
The FDA's decision on the sBLA for Abecma will be delayed beyond the set PDUFA target date of 16 December.
Bio Pharma Dive
NOVEMBER 21, 2023
Studying somatic mutations could be “the next wave of opportunity” to develop more precise medicines, said Mike Stratton, one of Quotient’s scientific co-founders.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmaceutical Technology
NOVEMBER 21, 2023
The new scheme will launch in 2024 and aims to save the National Health Service (NHS) £14bn over five years.
Bio Pharma Dive
NOVEMBER 21, 2023
Surging demand for GLP-1 agonists has put medtech firms like Medtronic under pressure, even as they argue the hit to their businesses will be minimal.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Bio Pharma Dive
NOVEMBER 21, 2023
In a deal worth up to $610 million, Merck will gain a pipeline of neuroscience and rare disease programs from a startup it previously backed.
Fierce Pharma
NOVEMBER 21, 2023
With litigation spanning many countries, the COVID-19 vaccine giants remain engaged in a heated patent war. | Moderna pledged to appeal after the European Patent Office ruled one of its patents invalid in the intellectual property battle that spans multiple countries.
Pharma Times
NOVEMBER 21, 2023
SMPaeds2 aims to advance precision medicines for children with relapsed cancer - News - PharmaTimes
Fierce Pharma
NOVEMBER 21, 2023
The U.S. Federal Trade Commission isn’t letting up in its effort to crack down on pharma’s alleged misuse of a patent mechanism in the FDA’s regulatory process. | The U.S. Federal Trade Commission isn't letting up in its effort to crack down on pharma's alleged misuse of a patent mechanism in the FDA's regulatory process. And it's Sanofi’s turn to land in the crosshairs.
Pharma Times
NOVEMBER 21, 2023
Cerebral SVD contributes to 45% of dementia cases and 20% of ischaemic strokes - News - PharmaTimes
Fierce Pharma
NOVEMBER 21, 2023
Texas has accused Pfizer and manufacturer Tris Pharma of knowingly providing compromised ADHD medicine to a state Medicaid program for children of low-income families. | In its lawsuit, Texas says the companies knew that deficient manufacturing processes compromised the effectiveness of Quillivant XR. The lawsuit further accuses the companies of manipulating quality-control testing from 2012 to 2018 to ensure samples received passing grades.
Pharmaceutical Technology
NOVEMBER 21, 2023
Despite a US FDA rejection for the drug earlier this year, the European Commission has approved Yorvipath for chronic hypoparathyroidism.
Fierce Pharma
NOVEMBER 21, 2023
Joining drugmakers like AstraZeneca and Novo Nordisk, GSK is making big strides in its quest to clean up its carbon footprint. | GSK plans to start late-stage trials of a low-carbon version of its metered dose inhaler (MDI) Ventolin utilizing a next-generation propellant in 2024. If the new product proves successful, it has the potential to slash greenhouse gas emissions from Ventolin use by roughly 90%.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharmaceutical Technology
NOVEMBER 21, 2023
Ensem will receive an upfront payment and will be eligible for additional payments upon the achievement of milestones, totalling up to $1.33bn.
Pharmaceutical Technology
NOVEMBER 21, 2023
Merck & Co will acquire all outstanding shares of Caraway, which has a preclinical-stage drug portfolio, through a subsidiary.
pharmaphorum
NOVEMBER 21, 2023
GSK says new inhaler will help slash its carbon footprint Phil.
Pharmaceutical Technology
NOVEMBER 21, 2023
Janssen has sought US FDA approval for the Rybrevant combination regimen for locally advanced or metastatic non-small cell lung cancer.
Fierce Pharma
NOVEMBER 21, 2023
After suffering setbacks in the clinic and in court over the last week, Bayer’s ability to overhaul its corporate structure is becoming more constricted, one group of analysts contends. | After suffering setbacks in the clinic and in court this week, Bayer’s ability to overhaul its corporate structure is becoming more constricted, one group of analysts contends.
Pharmaceutical Technology
NOVEMBER 21, 2023
Zevra Therapeutics has concluded the takeover of complete outstanding shares of Acer Therapeutics in a deal valued at $91m.
pharmaphorum
NOVEMBER 21, 2023
Digital measures for value-based healthcare: Current perspectives Mike.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Pharmaceutical Technology
NOVEMBER 21, 2023
Tooling is a crucial aspect in manufacturing medical devices, and developing plastic injection moulds in-house offers many advantages.
Rethinking Clinical Trials
NOVEMBER 21, 2023
Speakers Michael Ho, MD, PhD University of Colorado Sheana Bull, PhD University of Colorado Slides Keywords Nudge, Demonstration Project, Cardiovascular, Adherence Key Points A nudge is a strategic reminder that can help people adopt healthy behaviors, using principles from behavioral economics and cognitive psychology to improve behavior commitments, communicate social norms, and narrative stories.
Pharmaceutical Technology
NOVEMBER 21, 2023
MIRA Pharmaceuticals has signed a licencing agreement with MIRALOGX for the development and marketing of Ketamir-2 for depressive disorders.
pharmaphorum
NOVEMBER 21, 2023
In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Neil Weir, CEO of Sitryx Therapeutics, a smaller biotech that specialises in immunometabolism – a rapidly emerging and exciting area of investigation into the role of intracellular metabolic pathways in immune cells.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
BioSpace
NOVEMBER 21, 2023
In an SEC filing, the biotech launched by Flagship Pioneering said there was no viable alternative to dissolution as its cash ran out and anti-inflammatory assets failed to achieve clinical success.
pharmaphorum
NOVEMBER 21, 2023
Abecma delay gives Carvykti a chance to catch up Phil.
BioSpace
NOVEMBER 21, 2023
When twins Kenzie and Kaylie were diagnosed with Rett syndrome in 2016, there was no dedicated treatment for the neurodevelopmental disorder. That changed this year with the approval of Acadia Pharmaceuticals’ Daybue.
pharmaphorum
NOVEMBER 21, 2023
MSD reaches $610m deal to buy lysosome biotech Caraway Phil.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Expert insights. Personalized for you.
353 
Let's personalize your content